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ER stress sensing mechanism: Putting off the brake on UPR 
transducers
Diego Rojas-Rivera, Diego A. Rodriguez, Denisse Sepulveda and Claudio Hetz
Endoplasmic reticulum (ER) stress is a major 
contributor to cancer, metabolic disorders and 
neurodegenerative diseases. ER proteostasis maintenance 
is controlled by a dynamic signaling network known as 
the unfolded protein response (UPR). The mechanisms 
underlying the detection of a stressful condition at the ER 
are poorly understood and may involve the participation 
of ER chaperones and the direct recognition of misfolded 
proteins by specialized sensors. IRE1α is an ER-localized 
kinase and endoribonuclease that initiates the most 
conserved UPR signaling branch [1]. IRE1α catalyzes the 
unconventional splicing of the mRNA encoding the X-box 
binding protein 1 (XBP1), leading to the expression of an 
active transcription factor termed XBP1s. In addition, 
IRE1α regulates the stability of certain mRNAs and 
miRNAs through a process termed regulated IRE1α-
dependent decay (RIDD) [1]. Since ER stress is emerging 
as a driver of multiple human disorders, a complex 
network of regulatory checkpoints has evolved to tightly 
control its signaling behavior. We recently developed a 
systematic study to identify IRE1α binding partners and 
discovered a novel ER factor that is necessary for optimal 
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Figure 1: A. Working model. Under basal conditions monomeric IRE1α is maintained in an “Inactive” state by directly binding to ER 
the chaperone BiP via its ATPase domain (ATP). The ER factor Hsp47 transiently binds to IRE1α, promoting the release of BiP from the 
complex. BiP then associates with misfolded proteins through its substrate binding domain (SBD). These molecular events trigger IRE1α 
dimerization, autophosphorylation and oligomerization to catalize Xbp1 mRNA splicing and RIDD. After sustained ER stress, Hsp47 is 
released from the UPRosome complex. Finally, when ER stress is diminished by the UPR, BiP binds to IRE1α promoting its inactivation. B. 
To factors that regulate the UPR: under stress triggering IRE1α (alpha) activation. In contrast, Hsp47 is involved in the recognition of folded 
collagens for their export to the Golgi together with TANGO-1. Activation of the UPR not only triggers adaptive processes to mitigate ER 
stress and increase secretory cell function, but also enforces collagen biosynthesis and secretion, the main client of the ER.
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UPR signaling ([2] and see below). 
IRE1α is regulated by the assembly of a dynamic 
protein platform referred to as the UPRosome, which may 
control the stress threshold to engage the UPR, its temporal 
inactivation and the cross talk with other stress pathways 
[3]. How is IRE1α activated? Currently, two models are 
under debate: a direct recognition model where IRE1α 
operates as a stress sensor that binds misfolded proteins, 
and an indirect mechanism where IRE1α transduces 
stress signals coupled to ER chaperones. An early report 
indicated that the ER chaperone BiP binds to IRE1α to 
maintain its monomeric inactive state, an interaction that is 
lost under stress [4]. Elegant in vitro studies demonstrated 
that the ATPase domain of BiP allosterically associates 
and represses IRE1α (independent of ATP), whereas the 
binding of misfolded proteins to the substrate binding 
domain of BiP triggers the release of IRE1α [5]. A recent 
report added another piece to the puzzle by identifying 
the co-chaperone ERdj4 as a possible interface between 
IRE1α and BiP to repress the pathway [6]. Alternatively, 
other studies have suggested that misfolded proteins can 
associate with the luminal domain of IRE1α, allosterically 
inducing its activation [7]. 
The amplitude and kinetics of ER stress signaling 
are regulated by the binding of different cofactors to 
the main UPR transducers [1], however no systematic 
studies were available to define the nature of the IRE1α 
interactome. Using a proteomic screening, followed 
by functional validation, we unveiled Hsp47 as a novel 
regulator of the UPR transducer IRE1α. Cellular and 
biochemical characterization indicated that Hsp47 engages 
IRE1α signaling through a physical interaction, involving 
the release of BiP from the complex [2]. The control of 
IRE1α signaling by Hsp47 is evolutionary conserved as 
validated using D. melanogaster and mouse models of ER 
stress [2]. We propose that Hsp47 is part of a chaperone 
network that adjusts IRE1α signaling to set the stress 
threshold of activation to engage the UPR (Figure 1A). 
Hsp47 is a specialized cofactor for collagen 
biosynthesis, the most abundant protein in the cell and the 
main ER cargo. Hsp47, together with TANGO-1, guide 
the trafficking of the collagen triple helix into the Golgi 
apparatus for further maturation and secretion into the 
extracellular space. Thus, we speculate that the molecular 
connection identified here between Hsp47 and IRE1α 
may represent a central mechanism that adjusts the ER 
folding needs according to the production of collagen, 
where more collagen expression engages stronger IRE1α 
signals to improve the secretory capacity of the cell. Our 
study suggests that there are two types of signals to engage 
IRE1α: (i) abnormal misfolded proteins that de-repress 
the transducer through the binding to BiP and (ii) the 
increased production of properly folded collagens/Hsp47 
complexes (Figure 1B). Interestingly, XBP1s was recently 
shown to control TANGO-1, and Collagen-6a is also a 
major RIDD substrate, suggesting that maintaining an 
equilibrated pathway to fold collagen is a major challenge 
to the UPR. Moreover, recent studies in medaka fish 
indicated that most of the abnormal phenotypes triggered 
by the genetic disruption of major UPR components 
are due to the accumulation of misfolded collagens 
(see all references in [2]). Overall, we propose that the 
identification of Hsp47 as a positive regulator of IRE1α 
may reveal a tight relationship between collagen synthesis 
and UPR activation as a feedback mechanism to cope 
with the synthesis and secretion of these complex cargoes. 
Since collagens are the main ER clients, and possibly 
the main problem under ER stress, our current study 
may contribute to our understanding of how fluctuations 
in the ER folding capacity are monitored and adjusted 
to maintain proteostasis and its relation to pathological 
conditions such as fibrosis.
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